Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription 02.06.2025 1 Arch Virol 1 BMJ 1 J Immunol 5 J Infect 1 J Virol 1 JAMA 2 PLoS Comput Biol 24 PLoS One 15 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. LIU X
   ACE2, a therapeutic target of COVID-19, needs to be treated with caution.
   Arch Virol. 2025;170:143.
   PubMed         Abstract available
   
   

   
   BMJ

2. IBRAHIM S, Siemieniuk RAC, Oliveros MJ, Islam N, et al
   Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis.
   BMJ. 2025;389:e081165.
   PubMed         Abstract available
   
   

   
   J Immunol

3. DING C, Chen Q, Shi Y, Liu J, et al
   Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination.
   J Immunol. 2025 Apr 15:vkae040. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

4. PETER RS, Sedelmaier L, Nieters A, Brockmann SO, et al
   Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study.
   J Infect. 2025;90:106500.
   PubMed         Abstract available
   
   
5. HOOG M, Westrhenen ESH, Winkel AM, Jong MD, et al
   Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: Pooled analyses of 11 COVID-19 cohorts.
   J Infect. 2025 May 9:106501. doi: 10.1016/j.jinf.2025.106501.
   PubMed         Abstract available
   
   
6. RIEDMANN U, Chalupka A, Richter L, Werber D, et al
   Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: a cohort study.
   J Infect. 2025 Apr 30:106497. doi: 10.1016/j.jinf.2025.106497.
   PubMed         Abstract available
   
   
7. OVERTON CE, Fyles M, Mellor J, Paton RS, et al
   SARS-CoV-2 test sensitivity and duration of positivity in the UK during the 2023/2024 Winter: A prospective cohort study based on self-reported data.
   J Infect. 2025;90:106485.
   PubMed         Abstract available
   
   
8. CHEN R, Hao Z, Ye J, Zhao X, et al
   Decoding Post-Mortem Infection Dynamics of SARS-CoV-2, IAV and RSV: New Insights for Public Health and Emerging Infectious Diseases Management.
   J Infect. 2025 Apr 21:106489. doi: 10.1016/j.jinf.2025.106489.
   PubMed         Abstract available
   
   

   
   J Virol

9. ZHANG Q, Zhang L, Li J, Zhang W, et al
   hnRNPM regulates influenza A virus replication through distinct mechanisms in human and avian cells: implications for cross-species transmission.
   J Virol. 2025 May 28:e0006725. doi: 10.1128/jvi.00067.
   PubMed         Abstract available
   
   

   
   JAMA

10. MOIN EE, Seewald NJ, Halpern SD
    Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
    JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

11. ZHANG R, Tai J, Yao Q, Yang W, et al
    Behavior-driven forecasts of neighborhood-level COVID-19 spread in New York City.
    PLoS Comput Biol. 2025;21:e1012979.
    PubMed         Abstract available
    
    
12. MEDINA CM, Palacios JA, Minin VM
    Accounting for reporting delays in real-time phylodynamic analyses with preferential sampling.
    PLoS Comput Biol. 2025;21:e1012970.
    PubMed         Abstract available
    
    

    
    PLoS One

13. REHMAN N, Mbuagbaw L, Mertz D, Muraca GM, et al
    Association between virtual visits and health outcomes of people living with HIV: A cross-sectional study.
    PLoS One. 2025;20:e0315880.
    PubMed         Abstract available
    
    
14. DHAR B, Sajid M
    On improving public health after COVID-19 epidemic: A fractal-fractional mathematical solutions with short memory effect and efficient optimal strategies.
    PLoS One. 2025;20:e0321195.
    PubMed         Abstract available
    
    
15. KUANG D, Gao X, Du N, Huang J, et al
    Wastewater surveillance as a predictive tool for COVID-19: A case study in Chengdu.
    PLoS One. 2025;20:e0324521.
    PubMed         Abstract available
    
    
16. HONDA R, Abe T, Baba T, Araki Y, et al
    Dissemination of local sub-variants of SARS-CoV-2 detected by detailed mutation analysis in wastewater-based epidemiology.
    PLoS One. 2025;20:e0317076.
    PubMed         Abstract available
    
    
17. HAN Z, Chen M, Wang Y
    The impact of COVID-19 stress on nurses' organizational deviance: A moderated mediation model.
    PLoS One. 2025;20:e0324992.
    PubMed         Abstract available
    
    
18. CAZER CL, Lawless JW, Mehta P, Wagner B, et al
    Prevalence of SARS-CoV-2 infection and immunity in a New York county in 2022 reveals frequent asymptomatic or undiagnosed infections.
    PLoS One. 2025;20:e0323659.
    PubMed         Abstract available
    
    
19. AXEN I, Weiss N, Skillgate E
    Manual therapists in Sweden during the COVID-19 pandemic -they remained in business, but how was their work environment and practice impacted?
    PLoS One. 2025;20:e0324245.
    PubMed         Abstract available
    
    
20. HEYDARI P, Meyer MN, Chabris CF
    Medical rationing choices of laypeople and clinicians are often illogical and inconsistent with their own stated preferences.
    PLoS One. 2025;20:e0322242.
    PubMed         Abstract available
    
    
21. ALTARE C, Kim K, Spiegel PB
    "Everything had stopped, no meeting, no gathering": Social interactions during the COVID-19 pandemic in the Central African Republic, the Democratic Republic of Congo, and Bangladesh.
    PLoS One. 2025;20:e0323108.
    PubMed         Abstract available
    
    
22. KENGNE KAMGA LS, Voordouw ACG, De Vries MC, Kemper S, et al
    The citizen's perception of a shared responsibility during the COVID-19 management: Insights from a focus group study across four European countries.
    PLoS One. 2025;20:e0322019.
    PubMed         Abstract available
    
    
23. RUSSO FF
    Testing policies during an epidemic: An economic analysis.
    PLoS One. 2025;20:e0322292.
    PubMed         Abstract available
    
    
24. POORBAUGH J, Sims JT, Zhang L, Chang CY, et al
    Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions.
    PLoS One. 2025;20:e0324242.
    PubMed         Abstract available
    
    
25. MANUEL DG, Bennett C, Brown E, Buckeridge DL, et al
    Developing an evaluation framework for public health environmental surveillance: Protocol for an international, multidisciplinary Delphi consensus study.
    PLoS One. 2025;20:e0310342.
    PubMed         Abstract available
    
    
26. SHIMIZU HE, Gomes AMT, Apostolidis T
    The social representations of Covid-19 among primary health care' users in the Federal district, Brazil: A psychosocial approach.
    PLoS One. 2025;20:e0323568.
    PubMed         Abstract available
    
    
27. MA X, Huang T, Song Y, Pan H, et al
    Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B.
    PLoS One. 2025;20:e0323708.
    PubMed         Abstract available
    
    
28. NYONGESA V, Kathono J, Mwavua S, Nyamai D, et al
    "If I tell you my problems, how will you perceive me?": A qualitative study of mental health knowledge, barriers, and opportunities for care among Kenyan adolescents during COVID-19.
    PLoS One. 2025;20:e0323907.
    PubMed         Abstract available
    
    
29. SONG MC, Ha J, Park S, Kang H, et al
    Mortality in severe serious adverse events following heterologous and homologous prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study.
    PLoS One. 2025;20:e0323736.
    PubMed         Abstract available
    
    
30. NATALIA YA, Molenberghs G, Neyens T, Hens N, et al
    Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination, and international travel across Belgian provinces in 2021.
    PLoS One. 2025;20:e0322017.
    PubMed         Abstract available
    
    
31. KULJANCIC D, Amidzic J, Ljubotin L, Siladji D, et al
    Clinical profile of alcohol dependent paintents according to Lesch Typology one year after the Covid-19 pandemic-comparative study.
    PLoS One. 2025;20:e0324851.
    PubMed         Abstract available
    
    
32. 
    Retraction: Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding.
    PLoS One. 2025;20:e0325170.
    PubMed        
    
    
33. COLMAN E, Kao R
    The impact of signal variability on COVID-19 epidemic growth rate estimation from wastewater surveillance data.
    PLoS One. 2025;20:e0322057.
    PubMed         Abstract available
    
    
34. WANG CN, Nguyen TTM, Nhieu NL, Chung YC, et al
    Performance evaluation of Vietnamese industrial goods and services during and post-COVID-19 era based on multi-criteria decision-making methods.
    PLoS One. 2025;20:e0323764.
    PubMed         Abstract available
    
    
35. VAN DER MOEREN N, van den Biggelaar R, Gast KB, Verweij JJ, et al
    The added diagnostic value of RT-PCR on faeces for the diagnosis of COVID-19.
    PLoS One. 2025;20:e0322543.
    PubMed         Abstract available
    
    
36. BENTAHAR I, Loubet P, Salipante F, Choquet C, et al
    Respiratory viruses Ct values and association with clinical outcomes among adults visiting the ED with lower respiratory tract infections.
    PLoS One. 2025;20:e0320503.
    PubMed         Abstract available
    
    

    
    Vaccine

37. RAHIMI HK, Jasim AA, Rezahosseini O, Harboe ZB, et al
    Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis.
    Vaccine. 2025;59:127293.
    PubMed         Abstract available
    
    
38. QUENTIN E, Ahmed I, Duong CH, Tubert-Bitter P, et al
    Covid-19 Vaccination During Pregnancy in France: a Descriptive Study of Uptake Using the National Healthcare data System.
    Vaccine. 2025;58:127223.
    PubMed         Abstract available
    
    
39. LUPTON D, Whitten T, Tay AK, Beek K, et al
    Mental health and psychosocial factors predicting concerns about the COVID-19 vaccine among refugee background and Australian-born women.
    Vaccine. 2025;58:127251.
    PubMed         Abstract available
    
    
40. AVERIN A, Quinn E, Atwood M, Weycker D, et al
    Cost-effectiveness of bivalent respiratory syncytial virus Prefusion F (RSVpreF) maternal vaccine among infants in the United States.
    Vaccine. 2025;58:127191.
    PubMed         Abstract available
    
    
41. SASAKI E, Hamaguchi I, Hasegawa H, Takahashi Y, et al
    Establishment of a novel adjuvant screening system for the development of intranasal vaccine adjuvants.
    Vaccine. 2025;58:127267.
    PubMed         Abstract available
    
    
42. MOORE DCBC, Nehab MF, Reis AT, Junqueira-Marinho MF, et al
    Childhood vaccine hesitancy: The power of metaphors.
    Vaccine. 2025;58:127221.
    PubMed         Abstract available
    
    
43. PATTYN J, Hanning N, Valckx S, Claessens T, et al
    Investigating the state of vaccine confidence among the general public and parents with children up to 13 years in Flanders (Belgium).
    Vaccine. 2025;58:127250.
    PubMed         Abstract available
    
    
44. MERRITT A, Bansal S
    Prison Vaccination in a pandemic: Geographic disparities and policy insights.
    Vaccine. 2025;58:127218.
    PubMed         Abstract available
    
    
45. PEARCE A, Henery P, Dundas R, Katikireddi SV, et al
    Socio-economic inequalities in uptake and timing of childhood vaccination: Taking a life course approach in an administrative cohort in Scotland.
    Vaccine. 2025;57:127222.
    PubMed         Abstract available
    
    
46. WANG-LU H, Valerio Mendoza OM, Chen S, Geldsetzer P, et al
    Regional mobility and COVID-19 vaccine hesitancy: Evidence from China.
    Vaccine. 2025;58:127179.
    PubMed         Abstract available
    
    
47. STEPANEK L, Nakladalova M, Borikova A, Horakova D, et al
    Measles-mumps-rubella booster and post-COVID-19 immunity: A retrospective cohort study.
    Vaccine. 2025;57:127232.
    PubMed         Abstract available
    
    
48. ADAME BJ, Corman SR, Von Feldt PA, Meneses CM, et al
    Reactance as a cause of COVID-19 vaccination hesitancy.
    Vaccine. 2025;57:127209.
    PubMed         Abstract available
    
    
49. ROULEAU I, Issa Kana KDN, Zafack JG, Viger YB, et al
    New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada.
    Vaccine. 2025;57:127217.
    PubMed         Abstract available
    
    
50. MALANGE V, Mohaissen T, Conway KM, Rhoads A, et al
    Influenza vaccination during early pregnancy and risk of major birth defects, US Birth Defects Study To Evaluate Pregnancy exposureS, 2014-2019.
    Vaccine. 2025;59:127297.
    PubMed         Abstract available
    
    
51. SEILER P, Kaplan BS, Brice DC, Duan S, et al
    Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus.
    Vaccine. 2025;60:127311.
    PubMed         Abstract available
    
    

    
    Virology

52. LENDE SSF, Rothemejer FH, Andreas M, Pedersen ML, et al
    Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis.
    Virology. 2025;610:110573.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.